Has John Hofbauer received payments from drug or device companies?

Yes. Drug and device makers reported $6,228 in general payments to John Hofbauer across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Hofbauer did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Hofbauer come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Hofbauer

Ophthalmology · Beverly Hills, CANPI 1891770111

Payments from drug & device makers

What this record shows

Bausch & Lomb, A Division Of Bausch Health US, LLC accounts for 61.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $4,331 and has fallen 97.7% since, to $98 in 2025.

$6,228in general payments, 2019–2025

Across 114 payments — averaging $54.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb, A Division Of Bausch Health US, LLC$4K
AbbVie$755
Alcon$295
Johnson & Johnson Surgical Vision, Inc.$258
Novartis$188
Kala Pharmaceuticals, Inc.$153
plus $783 from 12 others

What the payments were for

Speaking & faculty fees$3,10050%
Food & beverage$3,12850%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb, A Division Of Bausch Health US, LLC	26	$3,796
AbbVie(2 entities)	41	$755
Alcon	5	$295
Johnson & Johnson Surgical Vision, Inc.	2	$258
Novartis	8	$188
Kala Pharmaceuticals, Inc.	3	$153
Sight Sciences, Inc.	2	$151
Ivantis, Inc	2	$124
Aerie Pharmaceuticals, Inc.	4	$97
Tarsus Pharmaceuticals, Inc.	2	$72
Oyster Point Pharma, Inc.	3	$64
Eyevance Pharmaceuticals LLC	4	$61
Akorn, Inc.	3	$56
Akorn Operating Company LLC	3	$50
Sun Pharmaceutical Industries Inc.	2	$35
Omeros Corporation	2	$28
Mallinckrodt Hospital Products Inc.	1	$22
Shire North American Group Inc	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,228 in reported general payments places this provider in the 80th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Other ophthalmology in Beverly Hills

Raymond DouglasBeverly Hills$1.3M
Stuart StollBeverly Hills$673K
Daniel SchwartzSan Francisco$8M
Michael BerlinWest Hollywood$5.7M
Gilbert KlimanMenlo Park$1.5M
Kuldev SinghStanford$1.5M
John AffeldtLoma Linda$1.1M
Srinivas SaddaPasadena$1M
Sheri RowenNewport Beach$1M
Savak TeymoorianLaguna Hills$955K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →